Back to Agendas
CDER Town Hall
Session Chair(s)
Nancy D. Smith, PhD
Adjunct Professor, Temple University, FDA Alumni, United States
One of the many DIA Annual Meeting program highlights is the CDER Town Hall where leaders from the US FDA’s Center for Drug Evaluation and Research will participate in this interactive offering where members of the audience may submit questions. Topics to be discussed will be determined by the interest of the audience.
Attendees are welcome to submit questions of interest to the panel by emailing annualmeetingprogram@diaglobal.org; subject line: CDER Town Hall Q/A
Learning Objective : Summarize key issues discussed by CDER; Identify regulatory hot topics.
Speaker(s)
Panelist
Thomas W. Abrams, MBA, RPh
Retired, Director, Office of Prescription Drug Promotion, OMP, CDER, Former FDA, United States
Panelist
Gerald Dal Pan, MD, MHS
Director, Office of Surveillance and Epidemiology, CDER, FDA, United States
Panelist
Sandra Kweder, MD
Principal, Drug and Biological Products , Eliquent Life Sciences, United States
Panelist
Christine Moore, PhD
Executive Director, Global External Advocacy and Standards, Organon & Co., United States
Panelist
Theresa Mullin, PhD
Associate Center Director - CDER, FDA, United States
Panelist
Robert J. Temple, MD
Senior Advisor for Clinical Science, OCD and Immediate Office, OND, CDER, FDA, United States
Have an account?